RECCE PHARMACEUTICALS LTD — Director's Dealing 2023

Jun 25, 2023

Change of Director's Interest Notices – James Graham

Sydney Australia, 26 June 2023: Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q), the Company developing a New Class of Synthetic Anti-Infectives, is pleased to provide a notice of change of interests in Director holdings.

The Company advises that Chief Executive Officer James Graham has increased his shareholding through the on-market purchase of an additional 500,000 shares totalling AUD $306,871.75.

19th June –22nd June 2023
Person whose relevant interest changed	Price per share	Quantity On	Value ($)
James Graham (CEO & Managing Director)	0.566419	89,303	$ 50,582.92
	0.621541	248,955	$ 154,735.74
	0.62980	80,403	$ 50,637.81
	0.625964	81,339	$ 50,915.29
Total		500,000	$ 306,871.75

This announcement has been approved for release by Recce Pharmaceuticals Board.

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Recce Pharmaceuticals Ltd (Company)
ACN	124 849 065

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	James Graham
Date of last notice	22 June 2021

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and indirect interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Buttonwood Nominees Pty Ltdwith theshares being held on behalf of JamesGraham
Date of change	a)25 August 2022 (transfer)b)25 August 2022 (transfer)c)15 June 2023(transfer)d)19 June 2023e)20 June 2023f)21 June 2023g)22 June 2023

+ See chapter 19 for defined terms.

No. of securities held prior to change	Direct Interest
	1.2,840,332fullypaidordinary
	shares
	2.389,712ClassBPerformance
	Shares
	3.2,250,000 Unlisted Options
	Indirect Interest
	Mr. James Graham
	1.2,493,750fullypaidordinary
	shares
	2.356,250ClassBPerformance
	Shares
	Bulleen Pty Ltd
	1.697,850 fully paid ordinary shares
Class	Fully paidordinary shares
Number acquired	500,000 fully paid ordinary shares
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated	a)$50,582.92b)$154,735.74
valuation	c)$50,637.81
	d)$50,915.29
No. of securities held after change	Total numberof fully paid ordinary shares
	held after change:6,531,932
	Direct Interest
	1.262,347fully paidordinary shares
	2.389,712ClassBPerformance
	Shares
	3.2,250,000 Unlisted Options
	Indirect Interest
	Mr. James Graham
	1.356,250ClassBPerformance
	Shares
	Bulleen Pty Ltd1.769,585 fully paidordinary shares
	Buttonwood Nominees Pty Ltd
	1.5,500,000fullypaidordinary
	shares

+ See chapter 19 for defined terms.

Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buyback	1.(a) to (c) transfer of securitiesbetween entities controlled by MrGraham with no changeto MrGraham's relevant interest.
	2.(d) to (g) on-market purchases

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	N/A
Interest after change	N/A

Part 3 – +Closed period

Were the interests in the securities or contracts detailedabove traded during a +closed periodwhere prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

+ See chapter 19 for defined terms.